biotech

“If you want to get into biotech, I would say, hey, get some real, ah, subject matter expertise, because it is very important. Whereas in, in the consumer internet space, Because we are all consumers. It's less important.”

“So, so we do not look, for example, at cleantech or biotech because, you know, I know nothing about that space.”

“Over the last year or two, we've expanded the kinds of companies we fund, you know, we're doing, we funded aerospace companies and nuclear power companies and biotech, and I think we'll continue to expand that universe as sort of the cycles of software continu…”

“Because we make an effort not to invest in direct competitors, they, they're perfectly comfortable sharing ideas with each other. So we've been able to organize, you know, because we don't do biotech For instance, you know, we can have a CEO summit where every…”

“I really think that we're on, we're at the beginning of a thirty-year journey that's similar to the personal computer that is going to Be based on genomics, technology, and software.”

“The area of investing in, in the biotech side is, is one that I feel is, is underinvested. And there's a whole series of massive industries inside of biotech that need to be developed.”

“I think the place where it ends poorly is where somebody applies and assumes software-related models to non-software areas, and they don't think about the margin structure, and they don't think about dealing with physical goods, and that's where I think a lot …”

“And I think, you know, maybe sometimes focusing on the thesis of an investment can blind you to the fact that most of the value in biotech comes from the eventual trajectory of the company that's unpredictable at the start. And that trajectory is absolutely di…”

“Unlike investing in enterprise software or consumer investing, the depth of knowledge needed to invest in the area is extremely, extremely deep and usually involves a PhD in some one of the areas that you're gonna invest in, in bioengineering or biotech.”

“It's not unheard of to spend a million dollars on a deal and a large deal just on diligence.”

“And you can think about a category that I think is going to have the same type of growth over the next 10 to 20 years and has had the same type, if not more, Moore's law effects. It's life sciences, biotech, pharma.”

“I'll always be affiliated in some way with Bain Capital, helping Bain Capital. I'm going to continue to build the sports group, which I love, and then continue to invest in these areas like biotech and artificial intelligence and space on a venture basis.”

“I don't personally do bio because, you know, I speak to someone and they're like, we've cured cancer. And I speak to the next person and they're like, we've cured cancer. I'm like, I don't know.”